CellSafe · Est. 2009
CellSafe
We drive innovation in biotechnology through advanced technology and a rigorous quality system.
Established in 2009, CellSafe is a biotechnology company specializing in biosafety testing products including mycoplasma detection & elimination kits, CHO Residual DNA detection kit, RCL (Replication Competent Lentivirus) qPCR Detection kit, Residual Host Cell DNA kit and Adventitious Virus detection kit, essential for R&D and the production of cell therapy products.
Featured Products
ResidualQSearch™ Plus CHO DNA Quantitation Kit
HiSense™ cDNA Synthesis Master Mix
ViralQSearch™ Plus RCL qPCR Detection Kit
What We Supply
Biosafety Testing & Viral Vectors
About the Partner
About CellSafe
Established in 2009, CellSafe is a biotechnology company specializing in biosafety testing products including mycoplasma detection & elimination kits, CHO Residual DNA detection kit, RCL (Replication Competent Lentivirus) qPCR Detection kit, Residual Host Cell DNA kit, Adventitious Virus detection kit etc which are essential for R&D and the production of cell therapy products.
Company Story
More About CellSafe
Leader in Biopharmaceutical Safety Evaluation.
Leading biosafety testing in the field of biotech products including biosimilars, vaccines and advanced biopharmaceuticals, CellSafe has committed itself to research and development to ensure the safety and quality control of next-generation biopharmaceuticals by implementing its innovative technology. It has become the first company in Asia to have developed Mycoplasma qPCR detection and removal kits.